Related Experiment Videos

Clinical trials for heavily pretreated patients: update in 2006

Christine Katlama1, Jade Ghosn

  • 1University Pierre et Marie Curie Paris VI, Hopital Pitié-Salpetriere, Paris, France.

Current Opinion in HIV and AIDS
|April 18, 2009
PubMed
Abstract

Insights

New antiretroviral drugs offer hope for patients with treatment failure. These potent medications, including new protease inhibitors and novel drug classes, can help achieve undetectable viral loads in salvage therapy.

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Managing treatment failure in HIV/AIDS requires potent antiretroviral regimens.
  • Highly experienced patients often have multiple drug exposures and resistance.
  • Salvage therapy aims to control viral replication in treatment-experienced individuals.

Purpose of the Study:

  • To review recent clinical studies on new antiretroviral drugs for salvage therapy.
  • To evaluate new drugs with different resistance profiles or novel mechanisms of action.
  • To assess the impact of new drugs on managing treatment failure in complex patient cases.

Main Methods:

  • Review of recent clinical studies focusing on salvage therapy.
  • Analysis of data from trials involving new antiretroviral agents.
  • Evaluation of drug efficacy against resistant viral strains.

Main Results:

  • New antiretroviral drugs significantly enhance the potency of salvage regimens.
  • Drugs include novel protease inhibitors (e.g., tipranavir, darunavir) and new classes (fusion, entry, integrase inhibitors).
  • These agents are crucial for overcoming viral replication and resistance.

Conclusions:

  • New drugs have revolutionized salvage therapy, enabling more effective treatment regimens.
  • Achieving undetectable viral load is now a realistic goal in salvage therapy.
  • Potent new agents allow for a paradigm shift in managing treatment failure.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...